Wednesday, July 25, 2018

Nobel laureate sets up medical institute In ShenZhen




Aaron Ciechanover

LED by Aaron Ciechanover, winner of the Nobel Prize in Chemistry in 2004, an institute of precision and regenerative medicine was inaugurated at Chinese University of Hong Kong, Shenzhen (CUHKSZ) on Thursday morning.

Under the witness of the deputy mayor of Shenzhen, Gao Zimin, other government officials and the university's directors, it was announced at Wuzhou Guest House on Thursday that CUHKSZ's third lab led by a Nobel laureate had been officially set up.

The Ciechanover Institute of Precision and Regenerative Medicine will conduct researches in two main fields: the precision treatment of cancer and infectious diseases as well as regenerative medicine for diseases including Parkinson's disease, Alzheimer's disease, diabetes and some other types of diseases, the professor said.
"We will also be looking at integrating multiple disciplines at the university, such as medical engineering, chemistry, big data, computer science and others to cultivate researchers with diverse backgrounds," Ciechanover said during an interview after the inauguration.

Ciechanover is an Israeli biologist who won the Nobel Prize for characterizing the method that cells use to degrade and recycle proteins using ubiquitin. He joined the Shenzhen university as a Distinguished Professor last October.

Professor Xu Yangsheng, president of CUHKSZ, said that the Distinguished Professor brought top-notch researchers along with him to the university. Setting up the institute could better help the research teams bring their research results to everyday teaching in order to cultivate better students, said the president.

Xu also disclosed at the inauguration ceremony Thursday that the university will add a new biomedical engineering major this year.

Besides the newly inaugurated institute, the university has set up two other labs named after Noble Prize winners, namely the Arieh Warshel Institute of Computational Biology and an institute for new drug R&D led by Brian Kobilka.
The first two labs are part of the city's 10 major Nobel laureate labs under Shenzhen's strategy to become a global innovation hub.

Source:Shenzhen Daily

No comments:

Post a Comment